16 studies found for:    Nicox
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
Condition: Osteoarthritis
Interventions: Drug: Naproxcinod 375 mg bid;   Drug: Naproxcinod 750 mg bid;   Drug: Naproxen 500 mg bid;   Drug: placebo
2 Completed To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension
Conditions: Osteoarthritis;   Hypertension
Interventions: Drug: naproxcinod 375 mg bid;   Drug: naproxcinod 750 mg bid;   Drug: naproxen 250 mg bid;   Drug: naproxen 500 mg bid;   Drug: ibuprofen 600 mg tid
3 Completed A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
Condition: Renal Failure
Intervention: Drug: naproxcinod
4 Completed Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male
Condition: Pharmacokinetics
Interventions: Drug: naproxcinod 750 bid;   Drug: naproxcinod 3000 mg od;   Drug: naproxen 500 mg bid
5 Completed Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide
Condition: Renal Hemodynamics
Interventions: Drug: naproxcinod;   Drug: Naproxen;   Drug: placebo;   Drug: furosemide
6 Completed A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure
Conditions: Osteoarthritis;   Hypertension
Interventions: Drug: naproxcinod 375 mg -750 mg -1125 mg bid;   Drug: naproxen 250 mg - 500mg -750 mg bid
7 Completed A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects
Condition: Liver Disease
Intervention: Drug: naproxcinod
8 Completed Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
Condition: Osteoarthritis
Interventions: Drug: Placebo;   Drug: Naproxcinod 375 mg;   Drug: Naproxen;   Drug: Naproxcinod 750 mg
9 Completed Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Conditions: Osteoarthritis;   Osteoarthritis, Hip
Interventions: Drug: Naproxcinod;   Drug: Naproxen;   Drug: Placebo
10 Terminated A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Interventions: Drug: Calcitriol;   Drug: Naproxen-n-butyl nitrate
11 Recruiting ADenoVirus Initiative Study in Epidemiology in France
Condition: Viral Conjunctivitis
Intervention:
12 Not yet recruiting ADenoVirus Initiative Study in Epidemiology in UK
Condition: Viral Conjunctivitis
Intervention:
13 Recruiting ADenoVirus Initiative Study in Epidemiology in Germany
Condition: Viral Conjunctivitis
Intervention:
14 Recruiting ADenoVirus Initiative Study in Epidemiology in Spain
Condition: Viral Conjunctivitis
Intervention:
15 Completed Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)
Condition: Intermittent Claudication
Interventions: Drug: NCX-4016;   Drug: NCX4016 placebo
16 Completed Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma
Conditions: Primary Open Angle Glaucoma;   Ocular Hypertension;   Pigmentary Glaucoma;   Pseudoexfoliative Glaucoma
Interventions: Drug: PF-03187207 and Latanoprost Vehicle;   Drug: Latanoprost 0.005% and PF-03187207 Vehicle

Indicates status has not been verified in more than two years